Lacosamide Tablet, Film Coated
Product Images NDC 60687-698

11 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 60687-698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0658a0c8 F5ed B380 E063 6394a90afff5

0658a0c8 F5ed B380 E063 6394a90afff5
Lacosamide 200 mg blue, oblong, film-coated oral tablet imprinted with 'LAC' on one side and '200' on the other, manufactured by American Health Packaging.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of the active ingredient Lacosamide. The structure depicts its molecular framework with specific functional groups including an amide, an ether, and a benzene ring.*
FDA Label Image

Laco-fig1.jpg (Laco Fig1)

Laco-fig1.jpg (Laco Fig1)
A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose' comparing seizure reduction percentages among placebo and various doses of Lacosamide in three separate studies. The vertical axis shows seizure reduction percentages from 0% to 45%. Each study shows higher seizure reduction with Lacosamide doses (200 mg, 400 mg, 600 mg) compared to placebo, with statistically significant differences marked by asterisks.*
FDA Label Image

Laco-fig2.jpg (Laco Fig2)

Laco-fig2.jpg (Laco Fig2)
A line chart titled "Proportion of Patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4." It shows responder rates from -100% (worsening) to 100% (improvement) on the vertical axis and percent of patients from 100 to 0 on the horizontal axis. Four lines represent placebo (N=359), and Lacosamide at doses 200 mg/day (N=267), 400 mg/day (N=466), and 600 mg/day (N=202), illustrating the distribution of patient response rates per group.*
FDA Label Image

Figure 3 – Kaplan-meier Analysis Of Time To 2nd Pgtc Seizure (study 5) Analysis Set: Modified Full Analysis Set (Image 01)

Figure 3 – Kaplan-meier Analysis Of Time To 2nd Pgtc Seizure (study 5) Analysis Set: Modified Full Analysis Set (Image 01)
A responder rate curve chart showing the percentage of patients versus responder rate (equal to or greater), comparing placebo and three dosage levels of Lacosamide (200 mg/day, 400 mg/day, 600 mg/day). The chart illustrates improvement and worsening response rates among patient groups with sample sizes indicated for each group.*
FDA Label Image

50 mg Lacosamide Tablets Carton.jpg (50 mg Lacosamide Tablets Carton)

50 mg Lacosamide Tablets Carton.jpg (50 mg Lacosamide Tablets Carton)
Label for Lacosamide tablets, USP 50 mg oral film-coated tablets by American Health Packaging. The label includes the NDC 60687-676-57, packaging quantity of 60 tablets (6 x 10), and specifies prescription use only. It features storage instructions, a QR code for medication guide and prescribing information, and product protection warnings.*
FDA Label Image

50 mg Lacosamide Tablet Blister.jpg (50 mg Lacosamide Tablet Blister)

50 mg Lacosamide Tablet Blister.jpg (50 mg Lacosamide Tablet Blister)
Lacosamide 50 mg film-coated oral tablets label from American Health Packaging. The label features the product name, strength, dosage form, a barcode, and placeholder fields for expiration date and lot number. The layout is repeated multiple times on a single sheet.*
FDA Label Image

100 mg Lacosamide Tablets Carton.jpg (100 mg Lacosamide Tablets Carton)

100 mg Lacosamide Tablets Carton.jpg (100 mg Lacosamide Tablets Carton)
Label for Lacosamide 100 mg film-coated tablets, USP, in a 60-tablet carton (6 blister packs of 10 each). The label includes dosing and storage instructions, Rx only designation, and distribution by American Health Packaging, Columbus, Ohio.*
FDA Label Image

100 mg Lacosamide Tablet Blister.jpg (100 mg Lacosamide Tablet Blister)

100 mg Lacosamide Tablet Blister.jpg (100 mg Lacosamide Tablet Blister)
Labels for Lacosamide tablets USP 100 mg, film-coated, oral dosage form. Each label includes the product name, strength, barcode, lot number, expiry date placeholders, and American Health Packaging as the labeler based in Columbus, Ohio. The labels are printed in black text on a white background with a quality control symbol.*
FDA Label Image

200 mg Lacosamide Tablets Carton.jpg (200 mg Lacosamide Tablets Carton)

200 mg Lacosamide Tablets Carton.jpg (200 mg Lacosamide Tablets Carton)
Label for Lacosamide 200 mg film-coated tablets, USP, in a bottle containing 60 tablets (6 bottles of 10). The label includes NDC 60687-698-57, indicates prescription use only, and states the product is distributed by American Health Packaging. Storage instructions and dispensing guidelines for pharmacists are also shown.*
FDA Label Image

200 mg Lacosamide Tablet Blister.jpg (200 mg Lacosamide Tablet Blister)

200 mg Lacosamide Tablet Blister.jpg (200 mg Lacosamide Tablet Blister)
Labels for Lacosamide 200 mg film-coated tablets, USP. Each label includes the product name, strength, barcode, and space for lot number and expiration date. The labeler is American Health Packaging, Columbus, Ohio. The labels are arranged in a sheet format for packaging use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.